CD19 and psoriasis: The proportion of CD19+CD11b+ B cells in PBMCs frompatients with psoriasis vulgaris at the active stage and erythrodermic psoriasis(P<0.001), but not the stationary stage, and other different psoriasis (allP<0.01) was upregulated compared with HCs.